treatment,
2-sequence crossover multiple dose steady state study. The study was completed in 30 healthy
subjects (22 M/8 F; mean age 34 (20-50) years of age).
The
plasma concentration time course and pertinent pharmacokinetic parameters for
bupropion, its metabolites, and the PAWC are shown in the Figures and Table
below.

|
Mean
Steady State Plasma Concentration Time Course for Bupropion and Its
Metabolites After Administration of Test (solid circles) or Reference (open
squares) Formulations in Study 2543 (as Provided by Sponsor) |
18
Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page